Marea Therapeutics · 15 hours ago
Senior Director, Analytical Development
Marea Therapeutics is a clinical-stage biotechnology company focused on developing first-in-class therapies for cardioendocrine diseases. The Senior Director of Analytical Development will lead the analytical development strategy, oversee method development, and collaborate with cross-functional teams to support regulatory submissions and ensure compliance with industry standards.
BiotechnologyGeneticsLife Science
Responsibilities
Lead and implement the overall analytical development plan for the portfolio assets that encompass in-process controls, product release, characterization, comparability, impurity and residual testing, stability and degradation, physicochemical and biochemical characterization methods. Candidate is expected to work with external CDMOs and CTLs to find the most efficient and scientifically sound plan and implement it for manufacturing at the CDMOs
Oversee development and phase appropriate qualification or validation of analytical methods for release, stability, comparability and in-process testing
Collaborate cross functionally with process development, QA/QC, Regulatory CMC to support IND filings, BLAs and other regulatory documents
Guide method transfer and troubleshooting at contract testing labs and CDMOs
Personally engage in data review and method optimization for complex physicochemical and bioassay methods
Lead characterization studies to support structural elucidation, product profile variant assays (size, charge glycosylation) and in the future binding assays
Develop phase appropriate control and release strategy, specifications to support GMP manufacturing of drug substance and drug product
Provide necessary technical oversight of the development and QC activities at the CDMO/CTLs
Ensure compliance with ICH, cGMP and regulatory requirements
Plan and prioritize resources across programs in a lean, dynamic environment
Help establish Marea’s long-term analytical infrastructure, balancing external outsourcing with selective in-house build-out
Qualification
Required
PhD in Analytical Chemistry, Biochemistry or related discipline with 12+ years of relevant experience in biologics drug development focused on analytical development
Expertise in key analytical methods for development of monoclonal antibody drugs, including: HPLC/UPLC (SEC, IEC, RP), CE-SDS, IEF, mass spectrometry (intact and peptide mapping), ELISA, cell-based assays, binding kinetics
Proven experience in authoring content for regulatory submissions and preferably interacting with health authorities
Experience working with CDMOs and contract testing labs
Hands-on experience troubleshooting and optimizing complex analytical methods; ability to dive deep into technical data when needed
Track record of supporting programs through IND, late-stage development, and BLA, including direct regulatory interactions
Strong leadership skills specifically working cross-functionally with internal team and with external partners
Exceptional ability to flex between strategic planning and hands-on execution in a lean, start-up environment
Preferred
Experience with cell-based assays is desirable
Company
Marea Therapeutics
Marea is a biotechnology company that develops therapies and medications for the treatment of cardioendocrine illness patients.
Funding
Current Stage
Growth StageTotal Funding
$255.42MKey Investors
Third Rock Ventures
2024-06-18Series B· $190M
2024-06-18Series A· $65.42M
Recent News
Clinical Trials Arena
2026-01-16
2026-01-15
Company data provided by crunchbase